About this trial
The purpose of this study is to assess the effectiveness of a "Food is Medicine" (FIM) intervention on incidence of gestational diabetes mellitus (GDM) among pregnant women at risk for GDM within the Harris Health system.
Eligibility criteria
Qualifiers
pregnant women receiving care at Harris Health clinics
Medicaid eligible or receiving Medicaid
<=14 weeks gestation at the time of the first prenatal visit and study enrollment
meet the ACOG criteria for early screening for GDM (have a BMI of 30 or greater and at least one additional ACOG-designated risk factor for GDM from the following: Age > 35 years; Black, Hispanic, Native American, Asian American or Pacific Islander ethnicity; history of GDM in prior pregnancy; A1c level > 5.7 & < 6.4; history of hypertension, pregnancy hypertension, heart disease, HIV, high triglycerides, polycystic ovarian syndrome; Immediate family member (parent or sibling) has had diabetes)
Disqualifiers
report existing or pregestational T2DM
have hemoglobin A1c>=7
are prescribed insulin therapy or metformin upon first screening
Trial design
Treatments tested in this trial
- Food is Medicine (FIM) Intervention
- Standard of Care